Sign Up Today and Learn More About Advanced NanoTherapies Stock
Invest in or calculate the value of your shares in Advanced NanoTherapies or other pre-IPO companies through EquityZen's platform.
Advanced NanoTherapies Stock
Advanced NanoTherapies researcehes biodegradable functionalized nanoparticle technology.
About Advanced NanoTherapies Stock
Founded
2018
Headquarters
Los Gatos, CA, US
Industries
Software, Artificial Intelligence, Science and Engineering
Advanced NanoTherapies Press Mentions
Stay in the know about the latest news on Advanced NanoTherapies
Financings for June 4, 2026
bioworld • Jun 05, 2026
Advanced NanoTherapies Raises Over $31 Million Series B To Advance Dual-Drug Nanoparticle-Coated Balloon Platform
pulse2 • Jun 04, 2026
Advanced NanoTherapies Secures Over $31M Series B to Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for Vascular Treatment
biospace • Jun 03, 2026
Advanced NanoTherapies Secures Over $31M Series B to Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for Vascular Treatment
vcaonline • Jun 03, 2026
The U.S. government wants to see AI models before you do. Trump just signed an executive order requesting early access
techstartups • Jun 03, 2026
Advanced NanoTherapies Management
Leadership team at Advanced NanoTherapies
President, CEO, and Co-Founder
Marwan Berrada-Sounni
Co-Founder, Chief Medical Officer and President
Mehdi Shishehbor
Join now and verify your accreditation status to gain access to:
- Advanced NanoTherapies Current Valuation
- Advanced NanoTherapies Stock Price
- Advanced NanoTherapies Management
- Available deals in Advanced NanoTherapies and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Advanced NanoTherapies Cap Table and Funding History by Share Class and Liquidity Preferences
- Advanced NanoTherapies Revenue and Financials
- Advanced NanoTherapies Highlights
- Advanced NanoTherapies Business Model
- Advanced NanoTherapies Risk Factors
- Advanced NanoTherapies Research Report from SACRA Research
Trading Advanced NanoTherapies Stock
How to invest in Advanced NanoTherapies stock?
Accredited investors can buy pre-IPO stock in companies like Advanced NanoTherapies through EquityZen funds. These investments are made available by existing Advanced NanoTherapies shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Advanced NanoTherapies stock?
Shareholders can sell their Advanced NanoTherapies stock through EquityZen's private company marketplace. EquityZen's network includes over 460K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."